Reproducibility of p53 immunohistochemistry in bladder tumors

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 1854-1864

  McShane, Lisa M ^a   Aamodt, Roger ^a   Cordon Cardo, Carlos ^b,i   Cote, Richard ^c   Faraggi, David ^d   Fradet, Yves ^e   Barton Grossman, H ^f   Peng, Amy ^g   Taube, Sheila E ^a   Waldman, Frederic M ^h  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF HAIFA   (Israel)

^e UNIVERSITÉ LAVAL   (Canada)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g EMMES CORPORATION   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANALYTIC METHOD; ARTICLE; BLADDER TUMOR; CANCER GRADING; CANCER INVASION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REPRODUCIBILITY; TUMOR CELL;

ANALYSIS OF VARIANCE; HUMANS; IMMUNOHISTOCHEMISTRY; REPRODUCIBILITY OF RESULTS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0034030369     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Levine, A. J., Perry, M. E., Chang, A., Silver, A., Dittmer, D., Wu, M., and Welsh, D. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer, 69: 409-416, 1994.
3. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
4. Miller, C. W., Simon, K., Aslo, A., Kok, K., Yokota, J., Buys, C. H., Terada, M., and Koeffler, H. P. p53 mutations in human lung tumors. Cancer Res., 52: 1695-1698, 1992.
5. Spruck, C. H. III, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G., and Jones, P. A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784-788, 1994.
6. a bladder cancer. Int. J. Oncol., 3: 355-360, 1993.
7. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A., and Cote R. J. Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med., 331: 1259-1264, 1994.
8. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z-F., Sheinfeld, J., Fair, W. R., Herr, H. W., and Reuter, V. E. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst., 85: 53-59, 1993.
9. Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., and Levine, M. J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8: 531-539, 1988.
10. Banks, L., Matlashewski, G., and Crawford, L. Isolation of human TP53 specific monoclonal antibodies and their use in the studies of human TP53 expression. Eur. J. Biochem., 159; 529-534, 1986.
11. Esrig, D., Spruck, C. H. III, Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A., and Cote, R. J. p53 nuclear accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. Am. J. Pathol., 143: 1389-1397, 1993.
12. Cordon-Cardo, C., Dalbagni, D., Saez, G. T., Oliva, M. R., Zhang, Z-F., Rosai, J., Reuter, V. E., and Pellicer, A. P53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int. J. Cancer, 56: 347-353, 1994.
13. Dalbagni, G., Cordon-Cardo, C., Reuter, V., and Fair, W. Tumor suppressor alterations in bladder cancer. Surg. Oncol. Clin. N. Am., 4: 231-240, 1995.
14. Lutzker, S. G., and Levine, A. J. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med., 2: 804-810, 1996.
15. Stein, J. P., Ginsberg, D. A., Grossfeld, G. D., Chatterjee, S. J., Esrig, D., Dickinson, M. G., Groshen, S., Taylor, C. R., Jones, P. A., Skinner, D. G., and Cote, R. J. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J. Natl. Cancer Inst., 90: 1072-1079, 1998.
16. Cote, R. J., and Chatterjee, S. J. Molecular determinants of outcome in bladder cancer. Cancer J. Sci. Am., 5: 2-15, 1999.
17. Lipponen, P. K. Overexpression of p53 nuclear oncoprotein in transitional cell bladder cancer and its prognostic value. Int. J. Cancer, 53: 365-370, 1993.
18. Underwood, M. A., Reeves, J., Smith, G., Gardiner, D. S., Scott, R., Bartlett, J., and Cooke, T. G. Overexpression of p53 protein and its significance for recurrent progressive bladder tumours. Br. J. Urol., 77; 659-666, 1996.
19. Lianes, P., Charytonowicz, E., Cordon-Cardo, C., Fradet, Y., Grossman, H. B., Hemstreet, G. P., Waldman, F. M., Chew, K., Wheeless, L. L., and Faraggi, D. Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network. Clin. Cancer Res., 4: 1267-1271, 1996.
20. Jahnson, S., and Karlsson, M. G. Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystec-tomy. J. Urol., 160: 1291-1296, 1998.
21. Shi, S. R., Cote, R. J., and Taylor, C. R. Antigen retrieval: past, present, and future. J. Histochem. Cytochem., 45: 327-343, 1997.
22. Korn, E. L.. and Graubard, B. I. Analysis of Health Surveys, p. 30. New York: John Wiley & Sons, 1999.
23. Shah, B. V., Barnwell, B. G., and Bieler, G. S. SUDAAN User's Manual. Release 7.5. Research Triangle Park, NC: Research Triangle Institute, 1997.
24. McCullagh, P. Regression models for ordinal data. J. R. Stat. Soc. B, 42: 109-142, 1980.
25. Zeger, S. L., and Liang, K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 42: 121-130, 1986.